SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001016169-08-000037
Filing Date
2008-05-16
Accepted
2008-05-16 16:21:20
Documents
1
Period of Report
2008-05-14

Document Format Files

Seq Description Document Type Size
1 ljacob05152008_ex.html 4  
1 ljacob05152008_ex.xml 4 3883
  Complete submission text file 0001016169-08-000037.txt   6196
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10

Mailing Address C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Business Address C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVE NEW YORK NY 10022 2123198300
JACOB LEONARD S (Reporting) CIK: 0001049713 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 08842598